Same goal, Different molecular strategy – Which FVIIIa Mimetic Gets There How? – RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Jacob Lund et al, adding:
“Same goal. Different molecular strategy. Which FVIIIa mimetic gets there how?
This new RPTH study directly compares denecimig (Mim8), zemocimig (NXT007), and emicizumab under the same experimental conditions.
The next-generation mimetics take strikingly different routes:
- Zemocimig – highest FIXa–FX complex assembly affinity
- Denecimig – lower affinity, but dramatically higher catalytic activity
- Yet denecimig and zemocimig produced remarkably similar thrombin-generation profiles, with both showing greater potency than emicizumab.
Different engineering strategies – similar enhancement of hemostatic potential.
An intriguing mechanistic look at the evolving generation of FVIIIa-mimetic therapies for hemophilia A.”
Title: Mechanism of action and impact on thrombin generation of denecimig (Mim8), emicizumab, and zemocimig (NXT007): comparative analysis using sequence-identical analogs
Authors: Jacob Lund, Thomas Egebjerg, Jais Rose Bjelke, Mirella Ezban
More posts featuring RPTH Journal on Hemostasis Today.
-
Sep 3, 2026, 01:19Himanshu Aggarwal: 1 mg/kg/d Thalidomide Non-Inferior to Standard Dose in Transfusion-Dependent Thalassemia
-
Sep 3, 2026, 01:03SHOT Urges Safe Component Matching While NHSBT Appeals for Black Donors
-
Sep 3, 2026, 00:52David Wallace: FDA Approves MIMRYLO to Target Iron Regulation and Reduce Phlebotomy Burden
-
Sep 3, 2026, 00:33Hannah Isles: Interesting Link between Aging, Serotonin, Platelets and COVID-19 Severity
-
Sep 3, 2026, 00:22Danny Hsu: Paradigm Shift in PE Management? – Unpacking the PRAGUE-26 Trial
-
Sep 3, 2026, 00:14Leonardo Roever: Antiphospholipid Antibodies Present in 19% of Ischemic Stroke Cases
-
Sep 3, 2026, 00:03Jochebed Adwoa Sutherland: First Reported Case of Breast Mondor’s Disease in a Patient Living with Sickle Cell
-
Sep 2, 2026, 23:50Shashank Joshi: Individualized vs. Standard BP Control Shows Similar 90-Day Outcomes
-
Sep 2, 2026, 18:26Strengthening Comprehensive Care for Inherited Bleeding Disorders in Ecuador – World Federation of Hemophilia